GUMDROP : NCI - A Phase II Trial of Enzalutamide in Combination With PSA-TRICOM in Patients With Non-Metastatic Castration Sensitive Prostate Cancer

Created by Nancy Dawson, last modified on Jun 25, 2013
Description:To compare the safety and effectiveness of enzalutamide with and without vaccine therapy for advanced prostate cancer.
Link:http://clinicaltrials.gov/ct2/show/NCT01875250
Site:NIH
Principal Investigator:Ravi A Madan, M.D.